A Higher Cutoff for TSI Would Better Predict Recurrence in Patients With Graves’ Disease?

Introduction: GD is an autoimmune disease mediated by immunoglobulins (Igs) that activate TSH receptor (rTSH). Relapse after withdrawal of antithyroid drugs (ATD) can reach 60%. Measurement of TSH receptor antibodies (TRAb) and thyroid stimulating immunoglobulin (TSI) could be an indirect indicator...

Descripción completa

Detalles Bibliográficos
Autores principales: Fontes, Rosita, Negri, Maurício Massucati, Marui, Suemi, Gomes, Dalva Margareth Valente, Schrank, Yolanda, Castelar Pinheiro, Maria Fernanda Miguens, Fragoso Perozo, Andrea Faria Dutra, Araujo, Paula Bruna Mattos Coelho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089568/
http://dx.doi.org/10.1210/jendso/bvab048.1703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089568/
http://dx.doi.org/10.1210/jendso/bvab048.1703

Ejemplares similares